Tag: Mark Cummings
Firms advise on Insilico Medicine’s HKD2.28bn HKEX IPO
AI drug discovery firm Insilico Medicine listed on the HKEX main board on 30 December 2025
Firms act on Seyond’s HKEX debut in largest de-SPAC listing
LiDAR company Seyond debuts on the HKEX through a de-SPAC merger with TechStar on 10 December, raising HKD1.03 billion



















